FDA Approved: AZACTAM — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved a supplemental application for AZACTAM (aztreonam) from E.R. Squibb & Sons, L.L.C. The approval updates the product labeling for the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecological Infection
• Intra-abdominal Infection
• Lower Respiratory Tract Infection
• Septicemia
• Skin and Skin Structure Infection

Drugs mentioned

• Azactam (aztreonam)

Snippet

SUPPL AP for AZACTAM (AZTREONAM)